Director, TAIP TA Lead – Trial Analytics, Insights & Planning (TAIP) at Bristol-Myers Squibb

Princeton, New Jersey, United States

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Advanced degree preferred (MBA, MSc, MPH, PharmD, PhD, or equivalent) in a relevant field
  • 8+ years in management (incomplete in description, but implied as managerial experience)

Responsibilities

  • Lead analytics strategy and delivery across a portfolio of trials within assigned therapeutic area (TA)
  • Guide, support, and review work across study-level analytics leads, acting as both coach and strategic sounding board
  • Track delivery progress across trials, escalating risks and ensuring alignment with trial milestones and enterprise priorities
  • Partner with clinical, medical, and operational leadership, shaping trial strategy and portfolio-level planning through data-driven insights
  • Ensure cross-trial consistency and innovation in forecasting, feasibility modelling, performance dashboards, and protocol analytics
  • Promote global collaboration, coordinating across teams to ensure effective, scalable delivery
  • Lead discussions on cost implications of country mix and study design decisions at the portfolio level
  • Promote study optimization analytics across trials, including evaluation of patient and site burden and competitive landscape data
  • Coordinate field-based insights into TA-wide feasibility and site prioritization approaches
  • Champion use of platforms, tools, and data infrastructure that support delivery excellence
  • Integrate analytics with clinical supply planning where relevant to ensure delivery-readiness
  • Influence the evolution of TAIP capabilities, helping define best practices and raise the bar on analytics excellence across trials
  • Apply critical thinking to analyze complex data, challenge assumptions, and generate strategic, evidence-based recommendations

Skills

Trial Analytics
Feasibility Modeling
Strategic Planning
Resource Planning
Data-Driven Insights
Clinical Development
Analytics Strategy
Quality Control
Leadership
Coaching

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI